A pRb-independent mechanism preserves the postmitotic state in terminally differentiated skeletal muscle cells

被引:59
作者
Camarda, G
Siepi, F
Pajalunga, D
Bernardini, C
Rossi, R
Montecucco, A
Meccia, E
Crescenzi, M [1 ]
机构
[1] Higher Inst Hlth, Dept Environm & Primary Prevent, I-00161 Rome, Italy
[2] CNR, Ist Genet Mol, I-27100 Pavia, Italy
关键词
D O I
10.1083/jcb.200408164
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In skeletal muscle differentiation, the retinoblastoma protein (pRb) is absolutely necessary to establish definitive mitotic arrest. It is widely assumed that pRb is equally essential to sustain the postmitotic state, but this contention has never been tested. Here, we show that terminal proliferation arrest is maintained in skeletal muscle cells by a pRb-independent mechanism. Acute Rb excision from conditional knockout myotubes caused reexpression of E2F transcriptional activity, cyclin-E and -A kinase activities, PCNA, DNA ligase I, RPA, and MCM2, but did not induce DNA synthesis, showing that pRb is not indispensable to preserve the postmitotic state of these cells. Muscle-specific gene expression was significantly down-regulated, showing that pRb is constantly required for optimal implementation of the muscle differentiation program. Rb-deleted myotubes were efficiently reactivated by forced expression of cyclin D1 and Cdk4, indicating a functionally significant target other than pRb for these molecules. Finally, Rb removal induced no DNA synthesis even in pocket-protein null cells. Thus, the postmitotic state of myotubes is maintained by at least two mechanisms, one of which is pocket-protein independent.
引用
收藏
页码:417 / 423
页数:7
相关论文
共 33 条
  • [1] Reversible immortalization of human myogenic cells by site-specific excision of a retrovirally transferred oncogene
    Berghella, L
    De Angelis, L
    Coletta, M
    Berarducci, B
    Sonnino, C
    Salvatori, G
    Anthonissen, C
    Cooper, R
    Butler-Browne, GS
    Mouly, V
    Ferrari, G
    Mavilio, F
    Cossu, G
    [J]. HUMAN GENE THERAPY, 1999, 10 (10) : 1607 - 1617
  • [2] Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1)
    Cheng, MG
    Sexl, V
    Sherr, CJ
    Roussel, MF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (03) : 1091 - 1096
  • [3] Shared role of the pRB-related p130 and p107 proteins in limb development
    Cobrinik, D
    Lee, MH
    Hannon, G
    Mulligan, G
    Bronson, RT
    Dyson, N
    Harlow, E
    Beach, D
    Weinberg, RA
    Jacks, T
    [J]. GENES & DEVELOPMENT, 1996, 10 (13) : 1633 - 1644
  • [4] MITOTIC-CYCLE REACTIVATION IN TERMINALLY DIFFERENTIATED CELLS BY ADENOVIRUS INFECTION
    CRESCENZI, M
    SODDU, S
    TATO, F
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 1995, 162 (01) : 26 - 35
  • [5] Distinct phosphorylation events regulate p130-and p107-mediated repression of E2F-4
    Farkas, T
    Hansen, K
    Holm, K
    Lukas, J
    Bartek, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (30) : 26741 - 26752
  • [6] HOZAK P, 1994, J CELL SCI, V107, P2191
  • [7] Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis
    Ishida, S
    Huang, E
    Zuzan, H
    Spang, R
    Leone, G
    West, M
    Nevins, JR
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (14) : 4684 - 4699
  • [8] Reconstitution of cyclin D1-associated kinase activity drives terminally differentiated cells into the cell cycle
    Latella, L
    Sacco, A
    Pajalunga, D
    Tiainen, M
    Macera, D
    D'Angelo, M
    Felici, A
    Sacchi, A
    Crescenzi, M
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (16) : 5631 - 5643
  • [9] Reversal of growth suppression by p107 via direct phosphorylation by cyclin D1/cyclin-dependent kinase 4
    Leng, XH
    Noble, M
    Adams, PD
    Qin, J
    Harper, JW
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (07) : 2242 - 2254
  • [10] The retinoblastoma gene family in differentiation and development
    Lipinski, MM
    Jacks, T
    [J]. ONCOGENE, 1999, 18 (55) : 7873 - 7882